Your browser doesn't support javascript.
loading
Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML.
Sekeres, Mikkael A; Watts, Justin; Radinoff, Atanas; Sangerman, Montserrat Arnan; Cerrano, Marco; Lopez, Patricia Font; Zeidner, Joshua F; Campelo, Maria Diez; Graux, Carlos; Liesveld, Jane; Selleslag, Dominik; Tzvetkov, Nikolay; Fram, Robert J; Zhao, Dan; Bell, Jill; Friedlander, Sharon; Faller, Douglas V; Adès, Lionel.
Afiliación
  • Sekeres MA; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. msekeres@med.miami.edu.
  • Watts J; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
  • Radinoff A; University Hospital Sveti Ivan Rislki, Sofia, Bulgaria.
  • Sangerman MA; Institut Català d'Oncologia-Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet, Barcelona, Spain.
  • Cerrano M; Department of Molecular Biotechnology and Health Sciences, Division of Hematology, University of Turin, Turin, Italy.
  • Lopez PF; Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
  • Zeidner JF; University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • Campelo MD; University Hospital of Salamanca, IBSAL Institute for Biomedical Research of Salamanca, Salamanca, Spain.
  • Graux C; Department of Hematology, Université Catholique de Louvain, CHU UCL Namur (Godinne site), Yvoir, Belgium.
  • Liesveld J; The James P Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA.
  • Selleslag D; AZ Sint Jan Brugge-Oostende, Brugge, Belgium.
  • Tzvetkov N; MHAT Dr. Georgi Stranski, Clinic of Haematology, Pleven, Bulgaria.
  • Fram RJ; Millennium Pharmaceuticals, Inc. a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Zhao D; Millennium Pharmaceuticals, Inc. a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Bell J; Millennium Pharmaceuticals, Inc. a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Friedlander S; Millennium Pharmaceuticals, Inc. a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Faller DV; Millennium Pharmaceuticals, Inc. a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Adès L; AP-HP, Hôpital Saint Louis, Paris, France.
Leukemia ; 35(7): 2119-2124, 2021 07.
Article en En | MEDLINE | ID: mdl-33483617
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirimidinas / Azacitidina / Síndromes Mielodisplásicos / Leucemia Mielomonocítica Crónica / Leucemia Mieloide Aguda / Ciclopentanos / Inhibidores Enzimáticos / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirimidinas / Azacitidina / Síndromes Mielodisplásicos / Leucemia Mielomonocítica Crónica / Leucemia Mieloide Aguda / Ciclopentanos / Inhibidores Enzimáticos / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos